Home
AVBP
AVBP News

Latest ARRIVENT BIOPHARMA INC (AVBP) News on August 2, 2025

MT Newswires

a month ago

Oppenheimer Adjusts ArriVent BioPharma Price Target to $44 From $39, Maintains Outperform Rating

MT Newswires

a month ago

ArriVent BioPharma Says Interim Results From Lung Cancer Drug Trial Showed 16 Months Median Progression-Free Survival

ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study

GlobeNewswire

a month ago

ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

GlobeNewswire

a month ago

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

GOBankingRates

2 months ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone

GOBankingRates

2 months ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

GOBankingRates

2 months ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

2 months ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right

The Guardian

2 months ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

2 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Benzinga

2 months ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

2 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

3 months ago

Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans?

ArriVent BioPharma Reports First Quarter 2025 Financial Results

GlobeNewswire

3 months ago

ArriVent BioPharma Reports First Quarter 2025 Financial Results

ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

GlobeNewswire

3 months ago

ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

MT Newswires

4 months ago

B. Riley Initiates ArriVent BioPharma at Buy With $37 Price Target

ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts

Insider Monkey

4 months ago

ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts

MT Newswires

5 months ago

Guggenheim Initiates ArriVent BioPharma at Buy With $45 Price Target

ArriVent BioPharma Reports Full Year 2024 Financial Results

GlobeNewswire

5 months ago

ArriVent BioPharma Reports Full Year 2024 Financial Results

ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright

TipRanks

6 months ago

ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright

Intellia makes progress on HAE study; 2 more China drug deals

BioPharma Dive

6 months ago

Intellia makes progress on HAE study; 2 more China drug deals

MT Newswires

6 months ago

ArriVent BioPharma Enters Licensing Deal With Lepu Biopharma for Gastrointestinal Cancer Drug

ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers

GlobeNewswire

6 months ago

ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers

MT Newswires

9 months ago

ArriVent BioPharma's Q3 Net Loss Narrows

ArriVent BioPharma Reports Third Quarter 2024 Financial Results

GlobeNewswire

9 months ago

ArriVent BioPharma Reports Third Quarter 2024 Financial Results

Octagon Capital Advisors LP Increases Stake in ArriVent BioPharma Inc

GuruFocus.com

10 months ago

Octagon Capital Advisors LP Increases Stake in ArriVent BioPharma Inc

MT Newswires

a year ago

Oppenheimer Adjusts Price Target on ArriVent BioPharma to $39 From $35, Maintains Outperform Rating

MT Newswires

a year ago

ArriVent BioPharma Lung Cancer Treatment Study Shows Positive Interim Results

ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

GlobeNewswire

a year ago

ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

We're Not Very Worried About ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Rate

Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 27.26%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 27.26%: Read This Before Placing a Bet

MT Newswires

a year ago

ArriVent BioPharma Q2 Net Loss Narrows

ArriVent BioPharma Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

ArriVent BioPharma Reports Second Quarter 2024 Financial Results

ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer

GlobeNewswire

a year ago

ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer

ArriVent BioPharma, Inc. (NASDAQ:AVBP) institutional investors have had a good week as stock gains 19%

Simply Wall St.

a year ago

ArriVent BioPharma, Inc. (NASDAQ:AVBP) institutional investors have had a good week as stock gains 19%

MT Newswires

a year ago

Oppenheimer Initiates Coverage on ArriVent BioPharma With Outperform Rating, $35 Price Target

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

GlobeNewswire

a year ago

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

ArriVent Appoints John Hohneker, M.D., to its Board of Directors

GlobeNewswire

a year ago

ArriVent Appoints John Hohneker, M.D., to its Board of Directors

ArriVent BioPharma Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

ArriVent BioPharma Reports First Quarter 2024 Financial Results

ArriVent Appoints Kristine Peterson to its Board of Directors

GlobeNewswire

a year ago

ArriVent Appoints Kristine Peterson to its Board of Directors

ArriVent BioPharma Reports Full Year 2023 Financial Results

GlobeNewswire

a year ago

ArriVent BioPharma Reports Full Year 2023 Financial Results

enCore Energy Appoints Chief Legal Officer

CNW Group

2 years ago

enCore Energy Appoints Chief Legal Officer

Brinker International (EAT) Q2 Earnings: What To Expect

StockStory

2 years ago

Brinker International (EAT) Q2 Earnings: What To Expect

Why Virgin Galactic (SPCE) Outpaced the Stock Market Today

Zacks

2 years ago

Why Virgin Galactic (SPCE) Outpaced the Stock Market Today

The Andersons, Inc. to Release Fourth Quarter and Full Year Results on February 20

PR Newswire

2 years ago

The Andersons, Inc. to Release Fourth Quarter and Full Year Results on February 20

12 Most Promising Green Stocks According to Analysts

Insider Monkey

2 years ago

12 Most Promising Green Stocks According to Analysts

ConnectOne Bancorp, Inc. (NASDAQ:CNOB) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

ConnectOne Bancorp, Inc. (NASDAQ:CNOB) Q4 2023 Earnings Call Transcript

Are Investors Undervaluing Orla Mining Ltd. (TSE:OLA) By 25%?

Simply Wall St.

2 years ago

Are Investors Undervaluing Orla Mining Ltd. (TSE:OLA) By 25%?

Bubble Trouble: 7 Stocks to Sell Before the AI Bubble Bursts

InvestorPlace

2 years ago

Bubble Trouble: 7 Stocks to Sell Before the AI Bubble Bursts

Earnings Preview: DXC Technology Company. (DXC) Q3 Earnings Expected to Decline

Zacks

2 years ago

Earnings Preview: DXC Technology Company. (DXC) Q3 Earnings Expected to Decline

‘There’s an Upside Opportunity in the Residential Solar Sector,’ According to Truist — Here Are 2 Stocks to Take Advantage

TipRanks

2 years ago

‘There’s an Upside Opportunity in the Residential Solar Sector,’ According to Truist — Here Are 2 Stocks to Take Advantage

Afya Limited Announces Medical Seats Increase in FIP Guanambi

Business Wire

2 years ago

Afya Limited Announces Medical Seats Increase in FIP Guanambi

Republic Bancorp, Inc. Increases its Common Stock Cash Dividends Paid for the 26th Consecutive Year

Business Wire

2 years ago

Republic Bancorp, Inc. Increases its Common Stock Cash Dividends Paid for the 26th Consecutive Year

Why Fast-paced Mover AZZ (AZZ) Is a Great Choice for Value Investors

Zacks

2 years ago

Why Fast-paced Mover AZZ (AZZ) Is a Great Choice for Value Investors

AZZ (NYSE:AZZ) Is Paying Out A Dividend Of $0.17

Simply Wall St.

2 years ago

AZZ (NYSE:AZZ) Is Paying Out A Dividend Of $0.17

Associated Press Finance

2 years ago

OceanFirst: Q4 Earnings Snapshot

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

GlobeNewswire

2 years ago

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

Masimo Corporation (MASI) Stock Rallied 33.7% in Q4

Insider Monkey

2 years ago

Masimo Corporation (MASI) Stock Rallied 33.7% in Q4

Dividend Danger Zone: 3 High-Yield Stocks That Could Follow in Walgreens’ Footsteps

InvestorPlace

2 years ago

Dividend Danger Zone: 3 High-Yield Stocks That Could Follow in Walgreens’ Footsteps

enCore Energy Provides Update on South Texas Uranium Operations

PR Newswire

2 years ago

enCore Energy Provides Update on South Texas Uranium Operations

These 2023 Stock Market Losers Could Take Off in 2024

Motley Fool

2 years ago

These 2023 Stock Market Losers Could Take Off in 2024

1 Hyper Growth Stock Down 84% That You Don't Want to Miss

Motley Fool

2 years ago

1 Hyper Growth Stock Down 84% That You Don't Want to Miss

16 Best Mid-Cap Growth Stocks To Buy Now

Insider Monkey

2 years ago

16 Best Mid-Cap Growth Stocks To Buy Now

Executive Chairman David Schlanger Sells 66,002 Shares of Progyny Inc

GuruFocus.com

2 years ago

Executive Chairman David Schlanger Sells 66,002 Shares of Progyny Inc

Lemonade Announces Extension of CAC Financing Agreement with General Catalyst

Business Wire

2 years ago

Lemonade Announces Extension of CAC Financing Agreement with General Catalyst

DXC Technology to Report Third Quarter 2024 Results on Thursday, February 1, 2024

Business Wire

2 years ago

DXC Technology to Report Third Quarter 2024 Results on Thursday, February 1, 2024

ARKAY vs. AVNT: Which Stock Is the Better Value Option?

Zacks

2 years ago

ARKAY vs. AVNT: Which Stock Is the Better Value Option?

Capital Investment Trends At Omega Flex (NASDAQ:OFLX) Look Strong

Simply Wall St.

2 years ago

Capital Investment Trends At Omega Flex (NASDAQ:OFLX) Look Strong

New Strong Sell Stocks for January 9th

Zacks

2 years ago

New Strong Sell Stocks for January 9th

Avient To Hold Fourth Quarter 2023 Conference Call

PR Newswire

2 years ago

Avient To Hold Fourth Quarter 2023 Conference Call

TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

U.S. Silica (SLCA) Completes $25 Million Loan Repurchase

Zacks

2 years ago

U.S. Silica (SLCA) Completes $25 Million Loan Repurchase

First Mid Bancshares (NASDAQ:FMBH) shareholders have earned a 14% return over the last year

Simply Wall St.

2 years ago

First Mid Bancshares (NASDAQ:FMBH) shareholders have earned a 14% return over the last year

Those who invested in SunCoke Energy (NYSE:SXC) three years ago are up 183%

Simply Wall St.

2 years ago

Those who invested in SunCoke Energy (NYSE:SXC) three years ago are up 183%

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

InvestorPlace

2 years ago

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More

Zacks

2 years ago

Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More

Ingevity (NYSE:NGVT) shareholders have endured a 49% loss from investing in the stock five years ago

Simply Wall St.

2 years ago

Ingevity (NYSE:NGVT) shareholders have endured a 49% loss from investing in the stock five years ago

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%

Simply Wall St.

2 years ago

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%

Eastern Bank Named #1 SBA Lender in Massachusetts for the 15th Year in a Row

Business Wire

2 years ago

Eastern Bank Named #1 SBA Lender in Massachusetts for the 15th Year in a Row

16 Best Penny Stocks To Buy For 2024

Insider Monkey

2 years ago

16 Best Penny Stocks To Buy For 2024

Insider Sell: CEO Dhrupad Trivedi Sells 15,729 Shares of A10 Networks Inc (ATEN)

GuruFocus.com

2 years ago

Insider Sell: CEO Dhrupad Trivedi Sells 15,729 Shares of A10 Networks Inc (ATEN)

Eastern Bank Earns Top Score for 10th Consecutive Year in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index

Business Wire

2 years ago

Eastern Bank Earns Top Score for 10th Consecutive Year in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index

Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

Zacks

2 years ago

Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

3 Stocks to Buy for a Rebounding Labor Market

InvestorPlace

2 years ago

3 Stocks to Buy for a Rebounding Labor Market

Ingevity (NGVT) Extends Distributorship With TRiiSO for Capa

Zacks

2 years ago

Ingevity (NGVT) Extends Distributorship With TRiiSO for Capa

AbCellera Biologics Insiders Added US$2.47m Of Stock To Their Holdings

Simply Wall St.

2 years ago

AbCellera Biologics Insiders Added US$2.47m Of Stock To Their Holdings

Why It Might Not Make Sense To Buy P10, Inc. (NYSE:PX) For Its Upcoming Dividend

Simply Wall St.

2 years ago

Why It Might Not Make Sense To Buy P10, Inc. (NYSE:PX) For Its Upcoming Dividend

J&J Snack Foods Corp. (NASDAQ:JJSF) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

J&J Snack Foods Corp. (NASDAQ:JJSF) Q4 2023 Earnings Call Transcript

Kayne Anderson Private Credit Announces Strategic Minority Investment From Bonaccord Capital Partners

GlobeNewswire

2 years ago

Kayne Anderson Private Credit Announces Strategic Minority Investment From Bonaccord Capital Partners

Tango Therapeutics to Highlight Preclinical Data on PRMT5 Inhibitors at the Society for Neuro-Oncology (SNO) 28th Annual Meeting

GlobeNewswire

2 years ago

Tango Therapeutics to Highlight Preclinical Data on PRMT5 Inhibitors at the Society for Neuro-Oncology (SNO) 28th Annual Meeting

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Proto Labs Inc Earnings Call

Share on Social Networks: